@2024 Afarand., IRAN
ISSN: 1027-1457 Scientific Journal of Forensic Medicine 2019;25(2):61-64
ISSN: 1027-1457 Scientific Journal of Forensic Medicine 2019;25(2):61-64
Identification of Medicine Components in Herbal Drugs for Addiction Treatment; A Case Study of Zanjan City
ARTICLE INFO
Article Type
Original ResearchAuthors
Valipour R. (1)Shekari A. (*1)
Setareh M. (1)
Fakour K. (1)
(1) Legal Medicine Research Center, Legal Medicine, Organization, Zanjan, Iran
Correspondence
Address: Legal Medicine Research Center, Legal Medicine, Organization, Zanjan, IranPhone: +98 (24) 33445051
Fax: +98 (24) 33445051
ash61@gmx.com
Article History
Received: April 3, 2016Accepted: May 7, 2019
ePublished: June 20, 2019
BRIEF TEXT
Production and distribution of herbal drugs by herb sellers are increased for addiction treatment in recent years.
Opioids are one of the most commonly consumed substances worldwide and their most important complication is dependence and addiction [2]. [3-9]… One of the most important goals of addiction treatment is to stop illicit drug use, reduce relapse, decrease the severity and duration of relapse, and reduce the harm caused by addiction. The multidimensional nature of addiction requires an interdisciplinary approach to its management and treatment, and therefore holistic medicine is becoming increasingly important. In recent years, most addiction studies in Iran have focused on treatment with chemical drugs and cognitive-behavioral interventions [2] and currently, drug treatment for addiction is mainly performed using chemical drugs, such as methadone and buprenorphine [10]. [11-12]…
The aim of this study was to investigate the medicine components of herbal drugs for addiction treatment, collected from the herb shops of Zanjan city.
This is an experimental study.
This study was performed in Forensic Medicine laboratory of Zanjan city in 2014. A total of 143 specimens were collected from herb shops in Zanjan city (about 20 shops) and encoded and packaged in separate plastic zip bags.
The specimens were first weighed followed by weighing the internal contents of the specimens in capsule form. The sample’s information, including weight, internal capsule content weight, color and form were entered in pre-prepared sheets according to sample code and sample number and then 100 mg of each capsule was weighed and transferred to the test tube. The tablet-shaped specimens were first powdered and then inserted into the tube for the same amount as for the capsule specimens.
All samples were dissolved in 2 ml of methanol with high pressure liquid chromatography and prepared for injection into gas chromatography-mass spectrometry (GC-MS) and high performance liquid chromatography (HPLC). HPLC: we used HPLC device (KNAUER, Germany) with PDA Detector (Photodiode Array) and Eurospher 100-5 C18. The method used included 63% phosphate buffer (pH = 2.3) and 37% acetonitrile (1 ml/min) and adjusting the detector at 254 nm. The 20 µl of the sample was injected by Hamilton's syringe. Samples were injected into the apparatus after dilution several times and by passage of 0.22 micron filter. GC-MS: we used the 7890 GC-MS (Agilent; United States) equipped with HP-5MS (0.25 × 0.25 mm × 0.25 mm). MS software also included three sources of information, including Wily, Pest and NIST. The samples were dissolved in methanol gradient grade for chromatography and injected into MS-GC after passing 0.22 micron filter. The temperature was set at 60°C for one min, 210°C for 5 min and 20°C for one min. The injection temperature was 250°C and the transferring temperature was 280°C. Sample size was 0.1 µl and 1.5 ml/min and injection method was split ratio of 50:1. Finally, data were analyzed by SPSS 19 software.
In 143 samples, 31 samples (21.7%) had no drug composition and 112 samples (78.3%) had at least one drug composition. In terms of drug form, 107 samples (74.8%) were in capsule form and 34 samples (23.8%) were in tablet form, and syrup and drop each had the least frequency (0.7%). The most common drug composition was tramadol, followed by diphenoxylate and atropine (Table 1). Regarding the number of drug combinations used in a drug, 51 samples (35.7%) had one compound, 23 samples (16.1%) had two compounds, 36 samples (25.2%) had three compounds and 2 samples (1.4%) had a combination of four compounds.
78.3% of the drugs collected from herb sellers had one or more narcotic compounds and 21.7% did not have any narcotic compounds, which is in line with the results of Rahimi Movaghar et al. [2] and Abbasi & Nazeri [13]. All findings indicate that synthetic narcotic compounds have been used in these drugs, but are offered as herbal remedies, which is consistent with the results of Khazan et al. [14] and because they often have the same composition, shapes and colors, they are made and distributed by one or more limited centers. Use of diphenoxylate and tramadol and other drugs without a prescription for those who want to withdraw not only cause withdrawal, but by symptomatic treatment of symptoms of deprivation syndrome, it induces withdrawal, but by symptomatic treatment of symptoms of deprivation syndrome induces the sense of withdrawal and by continual use of these compounds leads to addiction to substances other than primary addiction.
A similar study is suggested to be conducted all over Iran with the cooperation of the Iranian Anti-Narcotics Police and the examination and clinical intervention be done by clinicians in those who used these drugs.
Of the limitations of this study was the lack of providing all available anti-addiction drugs by herb sellers to the researcher and also the lack of access to those who used these drugs to monitor their clinical symptoms.
In most samples collected from herb shops, one or two medicine components of opium exists that the most abundant of them is tramadol, diphenoxylate, and atropine.
We would like to thank the respected the director and staff forensic medicine of Zanjan province and also the Forensic Medicine Research Center of Iran.
None declared.
The research was financially supported by the General Administration of Forensics Medicine of Zanjan Province.
TABLES and CHARTS
Show attach fileCITIATION LINKS
[1]Gobbi M, Moia M, Pirona L, Ceglia I, Reyes-Parada M, Scorza C, et al. p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro. J Neurochem. 2002;82(6):1435-43.
[2]Rahimi Movaghar A, Khastoo G, Fekri M, Akhondzadeh Sh. Treatment of addiction by medicinal herbs sellers in Tehran. Hakim Res J. 2008;11(3):11-9. [Persian]
[3]Shahraz S, Ghazani T. Iranpharma. Tehran: Teimourzadeh; 2008. [Persian]
[4]Goldstein DB, Goldstein A. Possible role of enzyme inhibition and repression in drug tolerance and addiction. Biochem Pharmacol. 1961;8(1):48.
[5]Gerrits MAFM, Lesscher HBM, Van Ree JM. Drug dependence and the endogenous opioid system. Eur Neuropsychopharmacol. 2003;13(6):424-34.
[6]Radbruch L, Grond S, Lehmann KA. A risk-benefit assessment of tramadol in the management of pain. Drug Saf. 1996;15(1):8-29.
[7]Shadnia S, Soltaninejad K, Heydari K, Sasanian G, Abdollahi M. Tramadol intoxication: A review of 114 cases. Hum Exp Toxicol. 2008;27(3):201-5.
[8]Loram LC, Mitchell D, Skosana M, Fick LG. Tramadol is more effective than morphine and amitriptyline against ischaemic pain but not thermal pain in rats. Pharmacol Res. 2007;56(1):80-5.
[9]Esmaeili MH, Parivar K, Yaghmaie P, Abbasi E, Jahani Hashemee H. Effects of Matricaria chamomilla extract injection into paragigantocellularis nucleus on morphine withdrawal signs in rats. J Adv Med Biomed Res. 2006;14(55):9-16. [Persian]
[10]Reed LJ, Glasper A, de Wet CJ, Bearn J, Gossop M. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: Possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?. J Clin Psychopharmacol. 2007;27(2):188-92.
[11]Nazari SM, Naseri M, Mokri A, Ghaffari F, Davati A, Kamalinejad M. Opium and opium addiction treatment in Persian traditional medicine. Med Hist J. 2012;3(9):133-50. [Persian]
[12]Najafi HR. The prohibition of selling medicines for drug treatment by sellers of medicinals herbs. J Darmangar. 2005;5:44. [Persian]
[13]Abbasi M, Nazeri A. Abuse of morphine and codeine (opium, alkaloids) within herbal drugs. J Urmia Univ Med Sci. 2004;14(4):304-8. [Persian]
[14]Khazan M , Hedayati M , Askari S, Azizi F. Content analysis of Chinese herbal pills for weight loss. Res Med. 2012;35(4):209-14. [Persian]
[2]Rahimi Movaghar A, Khastoo G, Fekri M, Akhondzadeh Sh. Treatment of addiction by medicinal herbs sellers in Tehran. Hakim Res J. 2008;11(3):11-9. [Persian]
[3]Shahraz S, Ghazani T. Iranpharma. Tehran: Teimourzadeh; 2008. [Persian]
[4]Goldstein DB, Goldstein A. Possible role of enzyme inhibition and repression in drug tolerance and addiction. Biochem Pharmacol. 1961;8(1):48.
[5]Gerrits MAFM, Lesscher HBM, Van Ree JM. Drug dependence and the endogenous opioid system. Eur Neuropsychopharmacol. 2003;13(6):424-34.
[6]Radbruch L, Grond S, Lehmann KA. A risk-benefit assessment of tramadol in the management of pain. Drug Saf. 1996;15(1):8-29.
[7]Shadnia S, Soltaninejad K, Heydari K, Sasanian G, Abdollahi M. Tramadol intoxication: A review of 114 cases. Hum Exp Toxicol. 2008;27(3):201-5.
[8]Loram LC, Mitchell D, Skosana M, Fick LG. Tramadol is more effective than morphine and amitriptyline against ischaemic pain but not thermal pain in rats. Pharmacol Res. 2007;56(1):80-5.
[9]Esmaeili MH, Parivar K, Yaghmaie P, Abbasi E, Jahani Hashemee H. Effects of Matricaria chamomilla extract injection into paragigantocellularis nucleus on morphine withdrawal signs in rats. J Adv Med Biomed Res. 2006;14(55):9-16. [Persian]
[10]Reed LJ, Glasper A, de Wet CJ, Bearn J, Gossop M. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: Possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?. J Clin Psychopharmacol. 2007;27(2):188-92.
[11]Nazari SM, Naseri M, Mokri A, Ghaffari F, Davati A, Kamalinejad M. Opium and opium addiction treatment in Persian traditional medicine. Med Hist J. 2012;3(9):133-50. [Persian]
[12]Najafi HR. The prohibition of selling medicines for drug treatment by sellers of medicinals herbs. J Darmangar. 2005;5:44. [Persian]
[13]Abbasi M, Nazeri A. Abuse of morphine and codeine (opium, alkaloids) within herbal drugs. J Urmia Univ Med Sci. 2004;14(4):304-8. [Persian]
[14]Khazan M , Hedayati M , Askari S, Azizi F. Content analysis of Chinese herbal pills for weight loss. Res Med. 2012;35(4):209-14. [Persian]